| Stage | VZ | % of rev | CXDO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $34.3B | 100.00% | $25M | 100.00% | VZ ×1362.60 |
| Gross profit | $21.2B | 61.86% | $24M | 94.28% | CXDO +32.4pp |
| Operating income | $8.7B | 25.21% | $1M | 4.30% | VZ +20.9pp |
| Pre-tax income | $6.8B | 19.87% | $1M | 4.54% | VZ +15.3pp |
| Net income | $5.3B | 15.50% | $1M | 4.44% | VZ +11.1pp |
| Stage | VZ | CXDO | Gap · A − B |
|---|---|---|---|
| Revenue | $34.3B100.00% | $25M100.00% | VZ ×1362.60 |
| Gross profit | 61.86%$21.2B | 94.28%$24M | CXDO +32.4pp |
| Operating income | 25.21%$8.7B | 4.30%$1M | VZ +20.9pp |
| Pre-tax income | 19.87%$6.8B | 4.54%$1M | VZ +15.3pp |
| Net income |
| 15.50%$5.3B |
| 4.44%$1M |
| VZ +11.1pp |
No disclosed counterparties: CXDO.
None